Bethany Barone Gibbs,Donovan Weekley,Erin E. Dooley,Bjoern Hornikel,William Boyer,Tyler D. Quinn,Kara M. Whitaker,Sylvia E. Badon,C. Barrett Bowling,Barbara Sternfeld,Kelley Pettee Gabriel
{"title":"Meeting Bouted versus Non-Bouted Physical Activity Guidelines and Health Outcomes in CARDIA","authors":"Bethany Barone Gibbs,Donovan Weekley,Erin E. Dooley,Bjoern Hornikel,William Boyer,Tyler D. Quinn,Kara M. Whitaker,Sylvia E. Badon,C. Barrett Bowling,Barbara Sternfeld,Kelley Pettee Gabriel","doi":"10.1249/mss.0000000000004162","DOIUrl":null,"url":null,"abstract":"Purpose: Moderate-to-vigorous intensity physical activity (MVPA) guidelines recommend ≥150 minutes/week. Initial guidelines required bouts lasting ≥10 minutes, yet recent guidelines include non-bouted MVPA, despite less established benefits. This analysis sought to compare associations of meeting bouted vs. non-bouted MVPA guidelines on incident hypertension, diabetes, ≥10% weight gain, and cardiorespiratory endurance. Methods: This secondary analysis in the CARDIA cohort study used 15-year follow-up data during midlife. Participants (n=1,924) recruited from four U.S. centers wore an ActiGraph 7164 when 38-55 years old. Accelerometer data were used to define three groups: below guidelines, meeting non-bouted guidelines only, and meeting bouted guidelines. Incident stage 2 hypertension, diabetes, and ≥10% weight gain were assessed during clinical visits at baseline and 5-, 10-, and 15-year follow-up. Follow-up cardiorespiratory endurance was estimated by a 6-minute walk test (6MWT) at the 15-year follow-up. Associations between MVPA guideline group and outcomes were evaluated using survival analysis or ordinal logistic regression in nested models with progressive covariate adjustment. Results: Mean MVPA differed across groups: below guidelines, 93±36 minutes/week; non-bouted guidelines, 291±120 minutes/week; bouted guidelines, 551±530 minutes/week (p<0.001). Prior to adjustment, hypertension-free, diabetes-free, and ≥10% weight gain-free survival, and follow-up endurance were higher in those meeting bouted guidelines compared to other groups. After covariate adjustment, meeting bouted guidelines remained associated with lower risk of ≥10% weight gain (hazard ratio, 0.66; 95% CI, 0.48, 0.92) and higher endurance (odds ratio, 2.20; 95% CI, 1.47, 3.30). When meeting guidelines and controlling for MVPA volume, a greater proportion of bouted vs. non-bouted MVPA was associated with higher endurance only. Conclusions: Meeting recommendations with bouted MVPA compared to non-bouted MVPA may provide greater health benefits for weight control and endurance.","PeriodicalId":18500,"journal":{"name":"Medicine & Science in Sports & Exercise","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine & Science in Sports & Exercise","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1249/mss.0000000000004162","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Moderate-to-vigorous intensity physical activity (MVPA) guidelines recommend ≥150 minutes/week. Initial guidelines required bouts lasting ≥10 minutes, yet recent guidelines include non-bouted MVPA, despite less established benefits. This analysis sought to compare associations of meeting bouted vs. non-bouted MVPA guidelines on incident hypertension, diabetes, ≥10% weight gain, and cardiorespiratory endurance. Methods: This secondary analysis in the CARDIA cohort study used 15-year follow-up data during midlife. Participants (n=1,924) recruited from four U.S. centers wore an ActiGraph 7164 when 38-55 years old. Accelerometer data were used to define three groups: below guidelines, meeting non-bouted guidelines only, and meeting bouted guidelines. Incident stage 2 hypertension, diabetes, and ≥10% weight gain were assessed during clinical visits at baseline and 5-, 10-, and 15-year follow-up. Follow-up cardiorespiratory endurance was estimated by a 6-minute walk test (6MWT) at the 15-year follow-up. Associations between MVPA guideline group and outcomes were evaluated using survival analysis or ordinal logistic regression in nested models with progressive covariate adjustment. Results: Mean MVPA differed across groups: below guidelines, 93±36 minutes/week; non-bouted guidelines, 291±120 minutes/week; bouted guidelines, 551±530 minutes/week (p<0.001). Prior to adjustment, hypertension-free, diabetes-free, and ≥10% weight gain-free survival, and follow-up endurance were higher in those meeting bouted guidelines compared to other groups. After covariate adjustment, meeting bouted guidelines remained associated with lower risk of ≥10% weight gain (hazard ratio, 0.66; 95% CI, 0.48, 0.92) and higher endurance (odds ratio, 2.20; 95% CI, 1.47, 3.30). When meeting guidelines and controlling for MVPA volume, a greater proportion of bouted vs. non-bouted MVPA was associated with higher endurance only. Conclusions: Meeting recommendations with bouted MVPA compared to non-bouted MVPA may provide greater health benefits for weight control and endurance.